SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

Craig-Hallum Maintains Buy on DiaMedica Therapeutics, Raises Price Target to $15

Craig-Hallum maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price target from $10 to $15.

Benzinga · 05/15/2020 15:47

Craig-Hallum maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price target from $10 to $15.